InvestorsHub Logo
Followers 18
Posts 440
Boards Moderated 0
Alias Born 02/02/2006

Re: None

Friday, 02/15/2013 10:50:38 AM

Friday, February 15, 2013 10:50:38 AM

Post# of 158400
MUST READ: Agreement with Dr. Vladimir Bogin and the Global Implications


$$$$Again, this is much much bigger than you could ever imagine$$$$

Dr. Vladmir Bogin agreed to serve as a member of the Scientific Advisory Board of Regen.

Excerpt from Agreement:

Dr. Bogin currently serves as President and CEO of Cromos Pharma LLC, a contract research organization that specializes in biopharmaceutical clinical outsourcing into Russia and Eastern Europe. From 2008 to 2009, Dr. Bogin served as Director of Boehringer Ingelheim (a privately held pharmaceutical company) where he was in charge of the phase IV program for Dabigatran Etexilate. Dr. Bogin studied medicine at the Yale University School of Medicine and the University of Rochester School of Medicine and Dentistry.

It is anticipated that members of Regen’s Scientific Advisory Board will also function as research consultants to the Company for consideration to be negotiated between the member and the Company on a case by case basis.

Source: http://www.sec.gov/Archives/edgar/data/1079282/000139390512000269/bmsn_8k.htm

$$$$SO LONG, SO STRONG...GO BMSN$$$$
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.